Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Thu., Mar. 28, 12:42 PM
Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.
Slide #63. Henry Schein, Inc. — Medivet
Acquirer: |
Henry Schein, Inc. (NASDAQ:HSIC) |
Acquiree: |
Medivet |
Details: |
Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today that it has signed a definitive agreement to acquire an 80% ownership position in privately-held Medivet S.A., a leading distributor of animal health products and services in Poland, with sales in 2012 of approximately $80 million. |
Schein (Henry) is a provider of health care products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. Co. conducts its business through two reportable segments: health care distribution; and technology and other services. The health care distribution reportable segment aggregates Co.'s global dental and medical operating segments. Co.'s global technology and other services group provides software, technology and other services to health care practitioners. Co.'s technology group offerings include practice management software systems for dental and medical practitioners.
Henry Schein SEC Filing Email Alerts Service
Open the HSIC Page at The Online Investor »
Open the HSIC Page at The Online Investor (in a new window) »
|
March 28, 2024 12:42 PM Eastern
Hold (2.44 out of 4)
3rd percentile
|
|